Inam Danish Khan1, Atoshi Basu2, Sheshadri Kiran3, Shaleen Trivedi4, Priyanka Pandit5, Anupam Chattoraj6. 1. Assistant Professor (Microbiology), Army College of Medical Sciences and Base Hospital, Delhi Cantt 110010, India. 2. Senior Adviser and Head (Pathology), Command Hospital (Eastern Command), Kolkata 700027, India. 3. Classified Specialist (Anaesthesia) and Critical Care Specialist, INHS Asvini, Colaba, Mumbai, India. 4. Classified Specialist (Anaesthesia), Command Hospital (Eastern Command), Kolkata 700027, India. 5. Graded Specialist (Microbiology), Command Hospital (Eastern Command), Kolkata 700027, India. 6. Brig I/C Adm and Cdr Tps, Command Hospital (Eastern Command), Kolkata 700027, India.
Abstract
BACKGROUND: Device-Associated Healthcare-Associated Infections (DA-HAI), including Ventilator-Associated Pneumonia (VAP), Central-Line-Associated Blood Stream Infection (CLABSI), and Catheter-Related Urinary Tract Infection (CAUTI), are considered as principal contributors to healthcare hazard and threat to patient safety as they can cause prolonged hospital stay, sepsis, and mortality in the ICU. The study intends to characterize DA-HAI in a tertiary care multidisciplinary ICU of a teaching hospital in eastern India. METHODS: This prospective outcome-surveillance study was conducted among 2157 ICU patients of a 760-bedded teaching hospital in Eastern India. Clinical, laboratory and environmental surveillance, and screening of HCPs were conducted using the US Centers for Disease Control and Prevention (CDC)'s National Healthcare Safety Network (NHSN) definitions and methods. RESULTS: With 8824 patient/bed/ICU days and 14,676 device days, pooled average device utilization ratio was 1.66, total episodes of DA-HAI were 114, and mean monthly rates of DA-HAI, VAP, CLABSI, and CAUTI were 4.75, 2, 1.4, and 1.25/1000 device days. Most common pathogens isolated from DA-HAI patients were Klebsiella pneumoniae (24.6%), Escherichia coli (21.9%), and Pseudomonas aeruginosa (20.2%). All Acinetobacter baumanii, >80% K. pneumoniae and E. coli, and >70% P. aeruginosa were susceptible only to colistin and tigecycline. One P. aeruginosa isolate was panresistant. CONCLUSION: Mean rates of VAP, CLABSI, and CAUTI were 14.4, 8.1, and 4.5 per 1000 device days, which are comparable with Indian and global ICUs. Patients and HCPs form important reservoirs of infection. Resolute conviction and sustained momentum in Infection Control Initiatives are an essential step toward patient safety.
BACKGROUND: Device-Associated Healthcare-Associated Infections (DA-HAI), including Ventilator-Associated Pneumonia (VAP), Central-Line-Associated Blood Stream Infection (CLABSI), and Catheter-Related Urinary Tract Infection (CAUTI), are considered as principal contributors to healthcare hazard and threat to patient safety as they can cause prolonged hospital stay, sepsis, and mortality in the ICU. The study intends to characterize DA-HAI in a tertiary care multidisciplinary ICU of a teaching hospital in eastern India. METHODS: This prospective outcome-surveillance study was conducted among 2157 ICU patients of a 760-bedded teaching hospital in Eastern India. Clinical, laboratory and environmental surveillance, and screening of HCPs were conducted using the US Centers for Disease Control and Prevention (CDC)'s National Healthcare Safety Network (NHSN) definitions and methods. RESULTS: With 8824 patient/bed/ICU days and 14,676 device days, pooled average device utilization ratio was 1.66, total episodes of DA-HAI were 114, and mean monthly rates of DA-HAI, VAP, CLABSI, and CAUTI were 4.75, 2, 1.4, and 1.25/1000 device days. Most common pathogens isolated from DA-HAI patients were Klebsiella pneumoniae (24.6%), Escherichia coli (21.9%), and Pseudomonas aeruginosa (20.2%). All Acinetobacter baumanii, >80% K. pneumoniae and E. coli, and >70% P. aeruginosa were susceptible only to colistin and tigecycline. One P. aeruginosa isolate was panresistant. CONCLUSION: Mean rates of VAP, CLABSI, and CAUTI were 14.4, 8.1, and 4.5 per 1000 device days, which are comparable with Indian and global ICUs. Patients and HCPs form important reservoirs of infection. Resolute conviction and sustained momentum in Infection Control Initiatives are an essential step toward patient safety.
Authors: J Y Choi; Y G Kwak; H Yoo; S-O Lee; H B Kim; S H Han; H J Choi; Y K Kim; S R Kim; T H Kim; H Lee; H K Chun; J-S Kim; B W Eun; D W Kim; H-S Koo; G-R Bae; K Lee Journal: J Hosp Infect Date: 2015-06-10 Impact factor: 3.926
Authors: Inam Danish Khan; Ajay Kumar Sahni; Reena Bharadwaj; Mahima Lall; A K Jindal; V K Sashindran Journal: Med J Armed Forces India Date: 2013-12-17
Authors: Victor D Rosenthal; Hu Bijie; Dennis G Maki; Yatin Mehta; Anucha Apisarnthanarak; Eduardo A Medeiros; Hakan Leblebicioglu; Dale Fisher; Carlos Álvarez-Moreno; Ilham Abu Khader; Marisela Del Rocío González Martínez; Luis E Cuellar; Josephine Anne Navoa-Ng; Rédouane Abouqal; Humberto Guanche Garcell; Zan Mitrev; María Catalina Pirez García; Asma Hamdi; Lourdes Dueñas; Elsie Cancel; Vaidotas Gurskis; Ossama Rasslan; Altaf Ahmed; Souha S Kanj; Olber Chavarría Ugalde; Trudell Mapp; Lul Raka; Cheong Yuet Meng; Le Thi Anh Thu; Sameeh Ghazal; Achilleas Gikas; Leonardo Pazmiño Narváez; Nepomuceno Mejía; Nassya Hadjieva; May Osman Gamar Elanbya; María Eugenia Guzmán Siritt; Kushlani Jayatilleke Journal: Am J Infect Control Date: 2011-09-10 Impact factor: 2.918
Authors: Margaret A Dudeck; Lindsey M Weiner; Katherine Allen-Bridson; Paul J Malpiedi; Kelly D Peterson; Daniel A Pollock; Dawn M Sievert; Jonathan R Edwards Journal: Am J Infect Control Date: 2013-12 Impact factor: 2.918
Authors: Inam Danish Khan; Geetanjali Gonimadatala; S Narayanan; Umesh Kapoor; Harleen Kaur; Anuradha Makkar; R M Gupta Journal: Med J Armed Forces India Date: 2021-10-28
Authors: Binjie Xu; Qiuhua Wei; M Ryan Mettetal; Jie Han; Lindsey Rau; Jinfeng Tie; Rhea M May; Eric T Pathe; Shravanthi T Reddy; Lauren Sullivan; Albert E Parker; Donald H Maul; Anthony B Brennan; Ethan E Mann Journal: J Med Microbiol Date: 2017-10-06 Impact factor: 2.472
Authors: B M Snyder; B T Montague; S Anandan; A G Madabhushi; A K Pragasam; V P Verghese; V Balaji; E A F Simões Journal: Epidemiol Infect Date: 2019-01 Impact factor: 2.451
Authors: Inam D Khan; Shahbaz A Khan; Bushra Asima; Syed B Hussaini; M Zakiuddin; F A Faisal Journal: J Infect Public Health Date: 2017-06-28 Impact factor: 3.718